SolventumSOLV财报
NYSE · 医疗保健 · 医疗保健技术
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
SOLV 2025财年Q4 Key Financial Metrics
营收
$2.0B
毛利润
$1.0B
营业利润
$125.0M
净利润
$63.0M
毛利率
51.4%
营业利润率
6.3%
净利率
3.2%
同比增长
-3.7%
EPS
$0.37
Solventum 2025财年Q4 财务摘要
Solventum 2025财年Q4营收 $2.0B（同比下降 3.7%），净利润 $63.0M（同比增长 103.2%）（净利率 3.2%）。销售成本 $971.0M，运营费用 $902.0M。
核心财务指标
| 总营收 | $2.0B |
|---|---|
| 净利润 | $63.0M |
| 毛利率 | 51.4% |
| 营业利润率 | 6.3% |
| 报告期 | 2025财年Q4 |
营收拆解
Solventum 2025财年Q4营收 $2.0B 共来自 5 个业务板块，最大板块 Infection Prevention And Surgical Solutions 贡献 $752.0M（占 37.6%）。
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Infection Prevention And Surgical Solutions | $752.0M | 37.6% |
| Cost Of Software And Rentals | $508.0M | 25.4% |
| Health Information Systems Segment | $347.0M | 17.4% |
| Dental Solutions Segment | $343.0M | 17.2% |
| Related Party | $14.0M | 0.7% |
Solventum 分部营收 — 季度趋势
Solventum 过去 4 个季度各业务板块营收走势，展示 Infection Prevention And Surgical Solutions和Cost Of Software And Rentals 等业务的变化。
| 业务分部 | 2025财年Q4 | 2025财年Q3 | 2025财年Q2 | 2025财年Q1 |
|---|---|---|---|---|
| Infection Prevention And Surgical Solutions | $752.0M | $722.0M | $750.0M | — |
| Cost Of Software And Rentals | $508.0M | $502.0M | — | — |
| Health Information Systems Segment | $347.0M | $345.0M | $339.0M | $329.0M |
| Dental Solutions Segment | $343.0M | $340.0M | $338.0M | $328.0M |
| Related Party | $14.0M | $22.0M | $22.0M | $20.0M |
Solventum 年度营收
Solventum 历年营收汇总，含各年度总量（例如 2025 年营收为 $8.3B）
Solventum 季度营收与净利润历史
Solventum 最近 8 个季度的营收、净利润及同比增速
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| 2025财年Q4 | $2.0B | -3.7% | $63.0M | 3.2% |
| 2025财年Q3 | $2.1B | +0.7% | $1.3B | 60.4% |
| 2025财年Q2 | $2.2B | +3.8% | $90.0M | 4.2% |
| 2025财年Q1 | $2.1B | +2.7% | $137.0M | 6.6% |
| 2024财年Q4 | $2.1B | — | $31.0M | 1.5% |
| 2024财年Q3 | $2.1B | +0.4% | $122.0M | 5.9% |
| 2024财年Q2 | $2.1B | +0.2% | $89.0M | 4.3% |
| 2024财年Q1 | $2.0B | +0.2% | $237.0M | 11.8% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $2.02B | $2.08B | $2.08B | $2.08B | $2.07B | $2.16B | $2.10B | $2.00B |
| 同比增长 | 0.2% | 0.2% | 0.4% | N/A | 2.7% | 3.8% | 0.7% | -3.7% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $14.71B | $14.58B | $14.74B | $14.46B | $14.53B | $15.07B | $13.97B | $14.29B |
| 总负债 | $10.86B | $11.71B | $11.55B | $11.50B | $11.27B | $11.43B | $8.99B | $9.24B |
| 股东权益 | $3.85B | $2.87B | $3.19B | $2.96B | $3.26B | $3.65B | $4.99B | $5.05B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $442.0M | $355.0M | $169.0M | $219.0M | $29.0M | $169.0M | $76.0M | $95.0M |